Research ArticleSystemic Lupus Erythematosus
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository
Elena Gkrouzman, Ecem Sevim, Jackie Finik, Danieli Andrade, Vittorio Pengo, Savino Sciascia, Maria G. Tektonidou, Amaia Ugarte, Cecilia B. Chighizola, H. Michael Belmont, Chary Lopez-Pedrera, Lanlan Ji, Paul Fortin, Maria Efthymiou, Guilherme Ramires de Jesus, D. Ware Branch, Cecilia Nalli, Michelle Petri, Esther Rodriguez, Ricard Cervera, Jason S. Knight, Tatsuya Atsumi, Rohan Willis, Maria Laura Bertolaccini, Hannah Cohen, Jacob Rand, Doruk Erkan and on behalf of APS ACTION+
The Journal of Rheumatology April 2021, 48 (4) 541-547; DOI: https://doi.org/10.3899/jrheum.200513
Elena Gkrouzman
1E. Gkrouzman, MD, MS, Hospital for Special Surgery, New York, New York, USA;
Ecem Sevim
2E. Sevim, MD, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, New York, USA;
Jackie Finik
3J. Finik, MPH, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA;
Danieli Andrade
4D. Andrade, MD, PhD, University of São Paulo, São Paulo, Brazil;
Vittorio Pengo
5V. Pengo, MD, University Hospital Padova, Padova, Italy;
Savino Sciascia
6S. Sciascia, MD, PhD, Center of Research of Immunopathology and Rare Diseases, University of Turin, Turin, Italy;
Maria G. Tektonidou
7M.G. Tektonidou, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece;
Amaia Ugarte
8A. Ugarte, MD, Hospital Universitario Cruces, Barakaldo, País Vasco, Spain;
Cecilia B. Chighizola
9C.B. Chighizola, MD, PhD, Clinical Immunology & Rheumatology Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy;
H. Michael Belmont
10H.M. Belmont, MD, Hospital for Joint Diseases, New York University, New York, New York, USA;
Chary Lopez-Pedrera
11C. Lopez-Pedrera, PhD, Rheumatology Service, IMIBIC/Reina Sofia Hospital, University of Cordoba, Cordoba, Spain;
Lanlan Ji
12L. Ji, MD, Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China;
Paul Fortin
13P. Fortin, MD, CHU de Québec-Université Laval, Québec City, Québec, Canada;
Maria Efthymiou
14M. Efthymiou, PhD, H. Cohen, MD, Haemostasis Research Unit, Department of Haematology, University College London, London, UK;
Guilherme Ramires de Jesus
15G. Ramires de Jesus, MD, MSc, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil;
D. Ware Branch
16D.W. Branch, MD, University of Utah and Intermountain Healthcare, Salt Lake City, Utah, USA;
Cecilia Nalli
17C. Nalli, MD, Rheumatology and Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy;
Michelle Petri
18M. Petri, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA;
Esther Rodriguez
19E. Rodriguez, MD, Hospital Universitario 12 de Octubre, Madrid, Spain;
Ricard Cervera
20R. Cervera, MD, PhD, FRCP, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain;
Jason S. Knight
21J.S. Knight, MD, PhD, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA;
Tatsuya Atsumi
22T. Atsumi, MD, PhD, Hokkaido University Hospital, Sapporo, Japan;
Rohan Willis
23R. Willis, MD, Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, Texas, USA;
Maria Laura Bertolaccini
24M.L. Bertolaccini, PhD, Academic Department of Vascular Surgery, King’s College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, UK;
Hannah Cohen
14M. Efthymiou, PhD, H. Cohen, MD, Haemostasis Research Unit, Department of Haematology, University College London, London, UK;
Jacob Rand
25J. Rand, MD, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA;
Doruk Erkan
26D. Erkan, MD, MPH, Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine, New York, New York, USA.
+
REFERENCES
- 1.↵
- 2.↵
- Garcia D,
- Erkan D
- 3.↵
- Levine SR,
- Salowich-Palm L,
- Sawaya KL,
- Perry M,
- Spencer HJ,
- Winkler HJ, et al.
- 4.↵
- Udry S,
- Latino JO,
- Belizna C,
- Perés Wingeyer S,
- Fernández Romero DS,
- de Larrañaga G
- 5.↵
- 6.↵
- 7.↵
- Erkan D,
- Derksen WJM,
- Kaplan V,
- Sammaritano L,
- Pierangeli SS,
- Roubey R, et al.
- 8.↵
- 9.↵
- Riancho-Zarrabeitia L,
- Daroca G,
- Muñóz P,
- López-Hoyos M,
- Haya A,
- Martinez-Taboada VM
- 10.↵
- 11.↵
- Pengo V,
- Ruffatti A,
- Legnani C,
- Testa S,
- Fierro T,
- Marongiu F, et al.
- 12.↵
- Galli M,
- Luciani D,
- Bertolini G,
- Barbui T
- 13.↵
- Kelchtermans H,
- Pelkmans L,
- de Laat B,
- Devreese KM
- 14.↵
- Broder A,
- Putterman C
- 15.↵
- Petri M,
- Avci M,
- Magder LS
- 16.↵
- Binder SR,
- Litwin CM
- 17.↵
- Sarabi ZS,
- Sahebari M,
- Rezaie AE,
- Norouzi MT,
- Hashemzadeh K,
- Mirfeizi Z
- 18.↵
- 19.↵
- 20.↵
In this issue
The Journal of Rheumatology
Vol. 48, Issue 4
1 Apr 2021
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository
Elena Gkrouzman, Ecem Sevim, Jackie Finik, Danieli Andrade, Vittorio Pengo, Savino Sciascia, Maria G. Tektonidou, Amaia Ugarte, Cecilia B. Chighizola, H. Michael Belmont, Chary Lopez-Pedrera, Lanlan Ji, Paul Fortin, Maria Efthymiou, Guilherme Ramires de Jesus, D. Ware Branch, Cecilia Nalli, Michelle Petri, Esther Rodriguez, Ricard Cervera, Jason S. Knight, Tatsuya Atsumi, Rohan Willis, Maria Laura Bertolaccini, Hannah Cohen, Jacob Rand, Doruk Erkan, on behalf of APS ACTION+
The Journal of Rheumatology Apr 2021, 48 (4) 541-547; DOI: 10.3899/jrheum.200513
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository
Elena Gkrouzman, Ecem Sevim, Jackie Finik, Danieli Andrade, Vittorio Pengo, Savino Sciascia, Maria G. Tektonidou, Amaia Ugarte, Cecilia B. Chighizola, H. Michael Belmont, Chary Lopez-Pedrera, Lanlan Ji, Paul Fortin, Maria Efthymiou, Guilherme Ramires de Jesus, D. Ware Branch, Cecilia Nalli, Michelle Petri, Esther Rodriguez, Ricard Cervera, Jason S. Knight, Tatsuya Atsumi, Rohan Willis, Maria Laura Bertolaccini, Hannah Cohen, Jacob Rand, Doruk Erkan, on behalf of APS ACTION+
The Journal of Rheumatology Apr 2021, 48 (4) 541-547; DOI: 10.3899/jrheum.200513